Thrombolysis with intravenous alteplase (recombinant tissue-type plasminogen activator)
continues to be the sole recourse for acute ischemic stroke therapy, provided that patients …

Fibrinolysis is a feature in the phylogeny of vertebrates. This review analyzes the fibrinolytic
mechanism in different species compared to healthy adult humans. Additionally, it …

Emerging infectious diseases represent a grave threat to animal and human populations in
terms of their impact on global health, agriculture and the economy. Vaccines developed for …

重组组织型纤溶酶原激活剂静脉溶栓是目前惟一一种证实有效的治疗急性缺血性卒中的药物.
在许多情况下, 费用低廉的尿激酶不失为一种较好的选择. 虽然溶栓治疗日趋成熟 …

急性缺血性卒中是神经系统的常见病, 其发病率, 致残率, 致死率均很高, 已成为严重的医学和
公共卫生课题. 抗血小板, 抗凝, 降纤和脑保护剂等的治疗效果并不理想, 所以寻找更有效的治疗 …

This anthology highlights the endurance, grit, and survival of people and nature adapting to
and overcoming imperfect events and circumstances and describes medical, political, and …

Haemostasis prevents leaks or obstructions within the blood vessels following three
interrelated sequences: formation of the haemostatic plug, platelet consolidation and …

The uterus with placenta, and other details were made available by Dr. Dalen Agnew,
Lansing, MI and the specimen came from a private collector and originated from the …

US8071091B2 - Non-neurotoxic plasminogen activating factors for treating stroke - Google
Patents US8071091B2 - Non-neurotoxic plasminogen activating factors for treating stroke …

The invention concerns the use and the production of non-neurotoxic plasminogen
activating factors, derived, for example, from the common vampire Desmodus rotundus …